The global erythromelalgia treatment market reach USD 1.98 Billion in 2022 and is expected to exhibit a CAGR of 5.3% over the forecast period 2023 to 2032 PUNE ...
In human genetic studies, it was found that activating Kv7 channel mutations can overcome severe chronic EM pain caused by hereditary neuronal sodium ion channel activating mutations DELRAY BEACH, FL ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results